Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001728117-26-000027
Filing Date
2026-04-24
Accepted
2026-04-24 16:01:21
Documents
20
Period of Report
2026-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A goss-20260423.htm   iXBRL DEF 14A 615093
6 GRAPHIC goss-20260423_g1.jpg GRAPHIC 150783
7 GRAPHIC goss-20260423_g2.jpg GRAPHIC 236278
8 GRAPHIC goss-20260423_g3.jpg GRAPHIC 301860
9 GRAPHIC goss-20260423_g4.jpg GRAPHIC 149342
10 GRAPHIC goss-20260423_g5.jpg GRAPHIC 79209
  Complete submission text file 0001728117-26-000027.txt   3554986

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20260423.xsd EX-101.SCH 4936
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT goss-20260423_def.xml EX-101.DEF 2310
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20260423_lab.xml EX-101.LAB 10314
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20260423_pre.xml EX-101.PRE 6707
23 EXTRACTED XBRL INSTANCE DOCUMENT goss-20260423_htm.xml XML 139494
Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38796 | Film No.: 26893450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)